Arterite de Takayasu
Summary
Definition
History and exam
Key diagnostic factors
- presença de fatores de risco
- claudicação dos membros superiores ou inferiores
- ausência de pulso(s)
- pressões arteriais desiguais
- sopros vasculares
- febre baixa
Other diagnostic factors
- ataque isquêmico transitório (AIT)
- mialgia
- artralgia
- perda de peso
- fadiga
- tontura no esforço físico dos membros superiores
- hipertensão
- acidente vascular cerebral (AVC)
- dor torácica
- dor abdominal
- diarreia
- dispneia
- hemoptise
- sudorese noturna
- vertigem
- síncope
- cefaleia
- sopro cardíaco
- sintomas visuais
- eritema nodoso
- pioderma gangrenoso
Risk factors
- predisposição genética
- sexo feminino
- idade <40 anos
- etnicidade asiática
Diagnostic tests
1st tests to order
- velocidade de hemossedimentação (VHS)
- proteína C-reativa
- angiotomografia (ATG)
- angiografia por ressonância magnética (ARM)
Tests to consider
- ultrassonografia com Doppler
- tomografia por emissão de pósitrons com fluordesoxiglucose radiomarcada (PET-FDG)
Algoritmo de tratamiento
todos os pacientes
Colaboradores
Autores
Kenneth J. Warrington, MD
Professor of Medicine
Mayo Clinic College of Medicine
Rochester
MN
Divulgaciones
KJW declares that he has received clinical trial support from Eli Lilly, BMS, and Kiniksa. He has received consulting fees and honoraria from Amgen and Sanofi. KJW is an author of a number of references cited in this topic.
Agradecimientos
Dr Kenneth J. Warrington would like to gratefully acknowledge Dr Steven R. Ytterberg and Dr Eric L. Matteson, previous contributors to this topic.
Divulgaciones
SRY declares that he was a sub-awardee of a grant from the US Food and Drug Administration for a pilot study of abatacept, a treatment for Takayasu's arteritis. SRY is also a member of the steering committee at the Vasculitis Clinical Research Committee. ELM declares that he has no competing interests.
Revisores por pares
Loic P. Guillevin, MD
Internal Medicine
Hopital Cochin-Paris University
St-Jacques
Paris
France
Divulgaciones
LPG declares that he has no competing interests.
Gene G. Hunder, MD
Department of Medicine
Division of Rheumatology
Mayo Clinic
Rochester
MN
Divulgaciones
GGH is an author of a reference cited in this topic. GGH declares that he has no other competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med. 2003 Jul 10;349(2):160-9. Resumen
Kerr GS. Takayasu's arteritis. Rheum Dis Clin North Am. 1995 Nov;21(4):1041-58. Resumen
Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021 Aug;73(8):1349-65.Texto completo Resumen
Pugh D, Karabayas M, Basu N, et al. Large-vessel vasculitis. Nat Rev Dis Primers. 2022 Jan 6;7(1):93.Texto completo Resumen
Isselbacher EM, Preventza O, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 Dec 13;80(24):e223-393. Resumen
Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis. 2022 Dec;81(12):1654-60.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Arterite de células gigantes
- Hipertensão essencial
- Sífilis
Más DiferencialesGuías de práctica clínica
- 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis
- 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Más Guías de práctica clínica
Inicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad